Moreover, miR-16 was found to be reduced in depressed patients’ cerebrospinal fluid (CSF), but not in blood, and when rats were treated with anti-miR-16 they exhibited depression-like behaviors, as well as increased levels of CSF serotonin and raphe nuclei SERT [156]. This evidence concerns the gene SLC6A4 and depressive symptom measurement.